Welcome to NDA

Europe's leading Regulatory Service provider

If anyone can make sure that the best possible medicines reach the patients without unnecessary delay – it’s NDA.

In all we do, our aim is to shorten the expensive and time consuming process of getting effective and reliable medicines to the market.

We can achieve this by providing our clients with an extensive portfolio of services that are optimised to meet the standards of the regulatory authorities.

Our clients benefit from our input into development plans and regulatory assistance during the complete life span of their products.

In short, we strive to bridge the communication gap between the regulated and the regulators – to the ultimate benefit of patients

Let’s not keep them waiting.
Let’s bring medicines to the world.

2008-06-12 Dr Karin Sewerin joins NDA as Head of the Biopharmaceuticals Unit

Karin_Sewerin.jpg

NDA, the European Regulatory Affairs consulting Group, is pleased to announce the appointment of Dr. Karin Sewerin as Head of the Biopharmaceuticals Unit.

Read more

2008-02-09 - NDA is recruiting Biopharmaceutical experts

We are looking for an experienced expert in biopharmaceuticals for a senior position at our office in the UK (Leatherhead, London area).

Read more